Pain Relief in Non-Operable Oral Cancer Patients.

A Prospective Randomized Double-Blind Comparative Study of Injection Bupivacaine Plain Versus Injection Bupivacaine with Triamcinolone Using Inferior Alveolar Nerve Block for Pain Relief in Non-Operable Oral Cancer Patients. - nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108697

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: inferior alveolar nerve block.: Study of Injection Bupivacaine Plain Versus Injection Bupivacaine with Triamcinolone Using Inferior Alveolar Nerve Block for Pain Relief in Non-Operable

Eligibility

Inclusion criteria

Inclusion criteria: Age more than 18. Non operable Ca oral cancer. moderate to severe pain. willing for the block.

Exclusion criteria

Exclusion criteria: Allergy to local anesthetics or corticosteroids. Infection at injection site. Bleeding disorders or on anticoagulant therapy. Severe systemic illness contraindicating nerve block. Pre-existing neuropathy in mandibular distribution. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Duration of analgesia (time from administration of inferior alveolar nerve block to first request for rescue analgesic).Timepoint: 6 months.	—

Secondary

Measure	Time frame
Total rescue analgesic consumption during the observation period. Time to onset of pain relief. Timepoint: 6 months.	—

Countries

India

Contacts

Public ContactDr Janhavi Dahake

Datta meghe institute of health sciences and research.

janhavidahake98@gmail.com09922155413

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026